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Mitochondrial Ca2+ handling plays an important role in energy production and various cellular sig-
naling processes. Mitochondrial Ca2+ uptake is regulated by the mitochondrial Ca2+ uniporter (MCU),
at least one non-MCU Ca2+ channel and possibly a mitochondrial ryanodine receptor. Two distinct
mechanisms mediate Ca2+ outward transport, the Na+-dependent (mNCX) and the Na+-independent
Ca2+ efﬂux. In recent years we gained more insight into the regulation and function of these differ-
ent Ca2+ transport mechanisms. However, the precise physiological role and the molecular structure
of all mitochondrial Ca2+ transporters and channels still has to be determined.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial Ca2+ uptake ﬁrst has been described in the early
1960s [1,2]. Since then it has been recognized that mitochondrial
Ca2+ handling plays a central role in cellular physiology and path-
ophysiology. Ca2+ inﬂux from the cytosol controls the rate of mito-
chondrial energy (ATP) production [3,4]. Intramitochondrial Ca2+
activates three dehydrogenases coupled to the Krebs cycle, i.e.
pyruvate dehydrogenase, isocitrate dehydrogenase, and a-keto
glutarate dehydrogenase [3]. Other loci within the metabolic path-
ways, such as the electron transport chain, the F0F1ATPase, and the
adenine nucleotide translocase, have also been suggested as Ca2+-
regulated sites [5]. Moreover, Ca2+ uptake modulates the spatial
and temporal proﬁle of intracellular Ca2+ signaling [6–10], regu-
lates mitochondrial motility and morphology [11], and may trigger
cell death [12].
Transport pathways of Ca2+ across the mitochondrial
membranes have been evaluated indirectly for several years by
measurement of Ca2+ gradients, ﬂuorescent and luminescentchemical Societies. Published by E
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iversity of Cologne Kerpener-
2397.indicators and more recently by targeted ﬂuorescent proteins (for
review see [13]). Additionally, some measurements of mitochon-
drial Ca2+ channels and transporters in reconstituted lipid bilayers
or liposomes are available, while direct current recordings of iso-
lated mitochondria or mitoplasts (vesicles of inner mitochondrial
membrane) are scarce [14,15].
2. Calcium permeation through the outer mitochondrial
membrane
The voltage dependent anion channel (VDAC) reconstituted in
lipid bilayers was shown to conduct Ca2+ in addition to monovalent
ions [16]. Ruthenium red completely closed VDACs in single or
multichannel experiments. The open conﬁguration of VDAC allows
passage of molecules up to approximately 5 kDa. Thus, initially it
was believed that the outer mitochondrial membrane is freely
permeable to Ca2+ through VDAC. However, more recent data has
suggested that VDAC can provide a barrier to free diffusion and
may tightly control Ca2+ permeation. In HeLa cells and skeletal
myotubes transient expression of VDAC enhanced the amplitude
of agonist-dependent increases in mitochondrial matrix Ca2+
concentration by allowing the fast diffusion of Ca2+ from the endo-
plasmic reticulum (ER) release sites to the inner mitochondrial
membrane [17]. In these experiments a higher number of VDAC
molecules could either have induced the formation of additional
microdomains and signaling units between the ER and mitochon-
dria or might have increased the outer membrane permeability
at these contact sites. Notably, in states with low permeabilitylsevier B.V. All rights reserved.
1976 U.C. Hoppe / FEBS Letters 584 (2010) 1975–1981to metabolites, i.e. in closed states, VDAC exhibited a higher
permeability to Ca2+ than that in the open state. Thus VDAC
closure, which may lead to protein release and apoptosis, seems
to favor Ca2+ ﬂux into mitochondria, which also may induce per-
meability transition and cell death [18].
3. Calcium permeation through the inner mitochondrial
membrane
The inner mitochondrial membrane allows only controlled pas-
sage of different ions to maintain the high membrane potential re-
quired for ATP synthesis. Ca2+ uptake across the inner
mitochondrial membrane is regulated by the mitochondrial Ca2+
uniporter (MCU), at least one non-MCU Ca2+ channel and possibly-40 mV
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Fig. 1. Two distinct voltage-gated mitochondrial Ca2+ channels in human cardiac m
conﬁguration demonstrating channels with small openings and high amplitudes (A; ImCa1
could be detected in mitoplasts of non-failing and failing human hearts with both chana mitochondrial ryanodine receptor (mRyR) [14,15,19,20]. Two dis-
tinct mechanisms mediate Ca2+ outward transport, the Na+-depen-
dent (mNCX) [21] and the Na+-independent Ca2+ efﬂux [22]. The
Ca2+-induced mitochondrial permeability transition is sometimes
also classiﬁed as an efﬂux mechanism, since Ca2+ as well as other
small ions and molecules may exit mitochondria through the per-
meability transition pore (PTP) that traverses both the inner and
outer mitochondrial membrane [12]. When large quantities of
Ca2+ are accumulated in the mitochondrial matrix, Ca2+ interacts
with cyclophilin D to induce opening of the PTP, which is addition-
ally modulated by several factors such as reactive oxygen species
(ROS), pH and DWm [23,24]. These mechanisms have been exten-
sively reviewed in the past years [13,19,25,26], so account of re-
cent data and their discussion will be the main focus here.0 mV
-100 mV
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itoplasts. Mitochondrial Ca2+ currents at Vm = 100 mV in mitoplast-attached
) and currents with wide openings and smaller amplitudes (B; ImCa2). ImCa1 and ImCa2
nels being less active in mitoplasts from failing myocardium.
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The most studied of the Ca2+ transport mechanisms is the MCU.
Ca2+ inﬂux was demonstrated to depend on the mitochondrial
membrane potential as predicted by the equation of electrochem-
ical diffusion [10]. Moreover, studies of passive mitochondrial
swelling demonstrated that Ca2+ transport was independent of
other ions and could be observed when pH was maintained stable
[27]. These results indicated that this Ca2+ uptake mechanism had
properties of a uniporter. The MCU is activated by Ca2+ concentra-
tions greater than 200 nM, which are usually only achieved within
cytosolic microdomains, and by physiological levels of polyamines
such as spermine [28,29]. The MCU can be inhibited by ruthenium
red at low concentrations (IC50 1 lM) or by its puriﬁed analogue
ruthenium 360 (IC50 5 nM). According to the Ca2+ uptake capacity
it has been estimated that the inner mitochondrial membrane con-
tains 10–40 MCU channels per lm2 [14].
Interestingly, indirect evidence determining mitochondrial Sr2+
release following incubation with SrCl2 under various experimen-
tal conditions indicated that the MCU was inhibited by external
EGTA plus free Mg2+ and by external adenine nucleotides [30].
Among the adenine nucleotides tested ATP (EC50 0.6 mM) was
the most potent inhibiter while ADP > AMP were less effective. Gi-
ven that the ATP analog AMPPNP was as effective as ATP, supports
the notion that ATP hydrolysis is not required to obtain this inhib-
itory action. Regulation of Ca2+ uptake by adenine nucleotides sug-
gests that the phosphorylation potential of the cell inﬂuences the
extent to which ATP synthesis is accelerated by transferring
adapted excitatory Ca2+ pulses from the cytoplasm to the mito-
chondrial matrix. A low phosphorylation potential would render
the MCU more active, causing more Ca2+ to be accumulated in re-
sponse to a pulse because ADP and AMP are less effective than ATP
at closing the channel. While this regulation and feedback mecha-
nism might be logical a second scenario has been discussed [30].
Given that a low cellular phosphorylation state increases free
Mg2+, and rising Mg2+ concentrations and decreasing ATP/ADP
ratios exhibit opposite effects on the MCU, the net effect on
mitochondrial Ca2+ uptake via the MCU might be maintained con-
stant at varying metabolic states. Further experiments are required
to determine the physiological consequence of these regulatory
processes.
Clapham’s group was able to directly record a highly selective
mitochondrial Ca2+ current in mitoplasts from COS-7 cells, which
was driven by the negative mitochondrial potential, they referred
to as IMiCa [14]. In whole-mitoplast conﬁguration an inward recti-
fying current with a current density approximating 55 pA/pF at
160 mV was obtained. Current size increased with rising Ca2+
concentration at the cytosolic site and exhibited a high half-satura-
tion of 20 mM (Ymax 105 mM). Unlike various other Ca2+ chan-BA 75
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Fig. 2. Amplitude histograms of ImCa1 (A) and ImCa2 (B) demonstrate only one main amplit
to ﬁve amplitudes (non-failing: 1.4, 2.6, and 3.6 pA; failing: 0.76, 1.46, 2.29, nels IMiCa lacked Ca2+-dependent inactivation. Notably, IMiCa was
inhibited by 200 nM ruthenium red or ruthenium 360, and showed
a selectivity series for divalent cations of the uniporter [14]. These
channel properties strongly suggest the notion that MiCa is the
MCU.
In inside-out recordings single-channels had multiple subcon-
ductance states between 2.6 and 5.2 pS at 160 mV. The open
probability markedly declined from about 99% around the physio-
logical mitochondrial membrane potential to approximately 11% at
80 mV, accounting for much of the inward rectiﬁcation of the
macroscopic IMiCa current over this range of voltages [14].
Based on these data and the assumption of additional non-MCU
Ca2+ uptake pathways we recently aimed to record Ca2+ currents
from human cardiac mitoplasts. Consistent with the previous sin-
gle Ca2+ channel recordings from COS-7 cells [14], we also chose
a [Ca2+]pipette of 105 mM but used the mitoplast-attached conﬁgu-
ration [15]. Voltage steps to 100 mV elicited a Ca2+ current with a
unitary conductance of 13.7 pS, referred to as mitochondrial Ca2+
channel type 1, mCa1 (Fig. 1A). Channel activity increased at more
negative potentials (higher open probability and availability, short-
er mean ﬁrst latency), making the channel effective for Ca2+ uptake
into energized mitochondria. The channel was not conducting Cl,
and was less or non-permeant for K+ in the presence of Ca2+, thus
preventing mitochondrial depolarization by these abundant ions.
ImCa1 could also be detected in mitoplasts from failing human
hearts (Fig. 1A). Notably, under failing heart conditions the sin-
gle-channel activity and gating of mCa1 was reduced, particularly
exhibiting a lower open probability, a longer mean closed time
and a prolonged mean ﬁrst latency, which resulted in slowed
Ca2+ uptake kinetics in comparison to non-failing mitochondrial
Ca2+ channels [15]. These observations were in agreement with
previous reports of reduced mitochondrial Ca2+ uptake in cardio-
myopathy and heart failure [31,32]. Detailed single-channel analy-
sis revealed that ImCa1 is composed of subconductance levels. ImCa1
from non-failing hearts exhibited three sublevels which were in-
creased to ﬁve sublevels under failing heart conditions (Fig. 2A),
suggesting impaired opening of single mCa1 channels in heart
failure.
Similar to the mitochondrial Ca2+ uptake via the MCU
[14,33,34], ImCa1 was inhibited by 200 nM ruthenium 360, although
no complete block was achieved. Pharmacological experiments of
mitoplasts from failing hearts showed a more pronounced rurheni-
um 360 inhibition. Moreover, spermine (1 mM), an activator of the
MCU [29], signiﬁcantly increased channel activity (Fig. 3) [15].
Thus, mCa1 channels seem to represent the humanMCU, and these
channels share some properties with MiCa channels recorded in
COS-7 cells, i.e. a similar range of single-channel conductance,
amplitude and Ca2+ ﬂux, an increased open probability at more
negative voltages, subconductance states, and sensitivity to75
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Fig. 3. Pharmacological characteristics of ImCa1/2. Analysis of the drug effects on
mCa1/2 availability from failing hearts. Spermine (1 mM) signiﬁcantly increased
both channel activities which were blocked – after wash-out – by 10 lM ruthenium
360 (Ru360). mCa1: control (n = 4), BayK 8644 (n = 4), spermine (n = 4), Ru360
(n = 4); mCa2: control (n = 4), BayK 8644 (n = 4), spermine (n = 4), Ru360 (n = 4).
*P < 0.05 vs. control.
1978 U.C. Hoppe / FEBS Letters 584 (2010) 1975–1981nanomolar ruthenium 360 concentrations, but differ markedly in
gating parameters like open and closed times, suggesting species
and/or tissue speciﬁc diversity of the MCU [14,15].
Several attempts have been made to purify the MCU.
Reconstitution of channels sensitive to ruthenium red and
enriched fractions with Ca2+ transport activity have been achieved
[35,36], but the molecular structure of the MCU remains unre-
solved. Trenker et al. suggested that the uncoupling proteins
UCP2 and UCP3 were essential for enabling ruthenium red-sensi-
tive Ca2+ uptake in mitochondria [37]. Overexpression of UCP2
and UCP3 in an endothelial cell line had no effect on basal mito-
chondrial Ca2+ concentration, ATP production or pH, but caused en-
hanced mitochondrial Ca2+ uptake and ATP synthesis when cells
were challenged with histamine. Conversely, siRNA mediated
knockdown of UCP2 and UCP3 decreased mitochondrial Ca2+
sequestration in this cell line, and mitochondria isolated from the
liver of UCP2/ mice showed no ruthenium red-sensitive inﬂux
of Ca2+. Notably, UCP2 and UCP3 which were mutated in a homol-
ogous region of the second intermembrane loop failed to enhance
mitochondrial Ca2+ uptake. However, expression of the wildtype
proteins in yeast, that do not exhibit ruthenium red-sensitive mito-
chondrial Ca2+ transport, was unable to induce such uptake, sug-
gesting that UCP2/3 might be essential but not sufﬁcient for
ruthenium red-sensitive Ca2+ sequestration.
The ﬁndings and conclusions of this paper were challenged by
Brookes et al. [32] as two independent laboratories failed to detect
any alteration in Ca2+ uptake in mitochondria isolated from liver,
skeletal muscle, heart or kidney of UCP2/ or UCP3/mice. Given
that UCP2 and UCP3 overexpression did not affect DWm, which it
possibly could do if functional UCP2/3 were indeed being ex-
pressed, these authors suggested that the uncoupling proteins
might have been present in a non-functional form [32]. Part of
the discrepant results might be due to different isolation methods
of mitochondria. However, the role of UCP2 and UCP3 proteins in
Ca2+ uptake remains highly controversial.
3.2. Rapid mode of mitochondrial Ca2+ uptake (RAM)
While the mitochondrial Ca2+ uniporter for years has been
considered the main mitochondrial Ca2+ uptake mechanism,increasing evidence suggests additional Ca2+ entry routes into
mitochondria [15,37,38].
Observations of a rapid increase of [Ca2+]m levels upon exposure
to a pulse of cytosolic Ca2+ in intact cells let Gunter and coworkers
to investigate Ca2+ uptake in isolated mitochondria upon rapid Ca2+
pulses mimicking those observed in the cytosol of many types of
cells in vivo following hormonal activation [38,39]. In liver mito-
chondria an initial rapid Ca2+ uptake followed by a slower Ca2+
sequestration mode was obtained, the latter of which exhibiting
properties consistent with the MCU [40]. Conductivity of the rapid
mode of Ca2+ uptake (RAM) was restored following a drop of exter-
nal [Ca2+] to 100 nM for approximately 0.75 s [40]. This provided
evidence for an external Ca2+ binding site with a Kd between 100
and 200 nM which closes the RAM. At a concentration of 0.1 nM
ruthenium red/mg of mitochondrial protein the slower (MCU-like)
Ca2+ uptake was suppressed, while the concentration necessary to
inhibit the RAM was over an order of magnitude higher than that
required to block the MCU [40]. Polyamines such as spermine in-
creased RAM. Besides liver the existence of a rapid mode of Ca2+
uptake was also proposed in isolated heart mitochondria with
however slightly different transport properties [41]. Ca2+ uptake
by RAM in heart mitochondria was complete by 0.75 s and re-
mained inactive for the remainder of a Ca2+ pulse [41]. Notably,
it took considerably longer (60–90 s) to fully rest RAM conductivity
in heart compared with liver mitochondria by a fall of extramito-
chondrial [Ca2+] to a level near 100 nM.
The underlying proteins of RAM are unknown and its physiolog-
ical role is a matter of debate. Given that the RAM in heart was
inactivated for over 1 min following a pulse of Ca2+, indicates that
it could not take part in any rapid mitochondrial Ca2+ transients or
beat-to-beat Ca2+ sequestration. Gunter and coworkers suggested
that the RAM is sufﬁcient to transport the minimum Ca2+ necessary
for activation of ATP production by producing a burst of [Ca2+]m
prior to equilibration which activates intramitochondrial Ca2+-sen-
sitive metabolic reactions, while this process minimizes both en-
ergy expenditure and the amount of Ca2+ that might induce
mitochondrial permeability transition [34].
3.3. Mitochondrial ryanodine receptor (mRyR)
Three different ryanodine receptor (RyR) isoforms (RyR1–3)
have been cloned with different pharmacological properties and
somewhat tissue speciﬁc expression [42]. Controversy remains
regarding the possible existence of a mitochondrial RyR [43,44].
In isolated rat heart mitochondria electron microscopy detected
gold-labelled antibodies against RyRs predominantly in the cristae
of the inner mitochondrial membrane [43]. Western blot analysis
identiﬁed a protein with a molecular mass of approximately
600 kDa in the inner mitochondrial membrane, which bound
[3H]ryanodine with high afﬁnity [43]. The use of subtype speciﬁc
antibodies indicated that the mitochondrial isoform might corre-
spond to the sarcoplasmic reticulum (SR) RyR of skeletal muscle,
i.e. RyR1. Conversely, others obtained immunoreactivity for RyRs
around perinuclear mitochondria but did not ﬁnd any evidence
supporting localization of RyRs to the mitochondrial inner
membrane [44].
While the proximity between mitochondria and SR might sug-
gest contamination by the SR-RyR, several characteristics of the
proposed mRyR in cardiomyocytes were distinct from cardiac SR-
RyR (i.e. RyR2) [43,45]. Because ryanodine preferentially binds to
the open state of the RyR, the binding of [3H]ryanodine is widely
used as an indicator of RyR activity. The mRyR exhibited a bell-
shaped Ca2+ dependence of [3H]ryanodine binding with maximal
binding at approximately pCa of 4.4 and complete block at pCa 2
reminiscent of RyR1. Moreover, unlike the cardiac SR-RyR, caffeine
hardly enhanced ryanodine binding in mitochondria [45].
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selectively the Ca2+ channel of RyR1 [46], suppressed pulsatile Ca2+
uptake into isolated heart mitochondria, and inhibited Ca2+-in-
duced mitochondrial swelling and oxidative phosphorylation.
Notably, concentrations less than 2 lM ryanodine increased mito-
chondrial swelling, indicating a biphasic response of mRyR to ryan-
odine also similar to RyR1 channels which are known to be
activated by low ryanodine concentrations.
The same group obtained the only available single-channel
recordings of mRyR in reconstituted lipid bilayers from puriﬁed
rat cardiac mitochondrial subfractions [20]. These experiments re-
vealed long-lasting openings and fast-ﬂickering openings with
subconductance states approximating 40% of the full conductance
level. Addition of low concentrations of Ca2+ increased channel
activity, i.e. increased the open probability and mean open time,
while imperatoxin A induced long-lasting subconductance states,
a typical modulation of all RyR isoforms by this compound [47].
In symmetrical 300 mM cesium the unitary conductance was
616 pS, which is in the range of RyR1 under similar experimental
conditions [20].
Since both, the mRyR and the MCU are inhibited by low concen-
trations of ruthenium red (1–5 lM) and by Mg2+ [43], some
authors discussed that mRyR might be the same as the MCU
[13]. However, the very different single-channel characteristics of
the MCU (MiCa, mCa1) versus the mRyR rather argue against this
notion [14,15].
According to the channel properties, mRyR appears to allow ra-
pid sequestration of Ca2+ at relatively low concentrations, and thus
could account for a physiological beat-to-beat Ca2+ uptake in the
heart. It has been speculated that as the ryanodine-sensitive path-
way becomes inhibited, the classical MCU might take over and ac-
count for mitochondrial Ca2+ uptake at higher, possibly more
pathologically, external Ca2+ concentrations [45].
3.4. Mitochondrial calcium channel type 2 (mCa2)
By patch-clamping the inner mitochondrial membrane of hu-
man cardiac mitoplasts we recently identiﬁed a novel mitochon-
drial Ca2+ channel, we named mitochondrial calcium channel
type 2, mCa2 [15]. Single-channel properties were clearly distinct
from those of the mCa1/MCU (Fig. 1). Compared to mCa1 channels,
mCa2 channels had (i) a smaller single-channel amplitude, (ii) low-
er conductance of 7.7 pS, (iii) longer openings (mean open times),
and (iv) a higher open probability compared with mCa2 channels
Moreover, mCa2 channels exhibited only one open state; no sub-
conductance levels were obtained (Fig. 2). Occasionally, both
mCa1 and mCa2 currents could be recorded in same patches, indi-
cating that these Ca2+ channels are not separately present and thus
characteristic for different mitochondrial subpopulations [48].
ImCa2 was unaffected by 200 nM ruthenium 360, but was signif-
icantly suppressed by 10 lM ruthenium 360 (Fig. 3), consistent
with reports suggesting a ruthenium red-insensitive/low-sensitive
mitochondrial Ca2+ uptake in addition to the classical ruthenium
red-sensitive MCU [33,37,41].
Similar to mCa1 channels mCa2 was also found in mitoplasts
form failing hearts but exhibited signiﬁcant reduction of channel
activity. Thus, decreased channel conductance of mCa2 might also
contribute to the observed suppressed mitochondrial Ca2+ seques-
tration under failing heart condition [31,32]. While mitochondrial
dysfunction in disease and aging mainly has been related to direct
alterations of the respiratory chain or DWm [49,50], these data
demonstrated reduced function of mitochondrial Ca2+ channels
and thus of an indirect modulator of energy and ROS production
in a disease known to be associated with profound changes of
intracellular Ca2+ homeostasis and metabolism [51]. Alterations
of the mitochondrial matrix composition (i.e. Ca2+-buffering/alkali-sation, matrix-free [Ca2+], H+-translocation, protein expression)
might also have contributed to the observed differences in mCa1/
2 channel properties of mitochondria from failing and non-failing
hearts. However, in addition to differences in the basal biophysical
channel behavior marked differences in the pharmacological
behavior under non-failing versus failing conditions were ob-
tained, supporting the hypothesis of (at least additional) changes
in channel structure, subunit composition or binding sites in dis-
eased state.
The molecular nature of the protein(s) mediating Ca2+ transport
of ImCa2 is unknown. While it might be speculated that the remain-
ing Ca2+ uptake in the presence of nanomolar concentrations of
ruthenium 360 was due to alternative Ca2+ pathways such as the
mNCX, addition of CGP37157 (10 lM), cyclosporin A (10 lM), dan-
trolene (10 lM), S()-BayK 8644 (10 lM) or xestospongin C
(10 lM) to the bath or pipette solution did not affect ImCa2, indicat-
ing that this Ca2+ current was not mediated by the mNCX [52],
mitochondrial PTP [53], mRyR [43], mitochondrial dihydropyridine
site [54] or an IP3-receptor [55]. Moreover, current characteristics
of ImCa2 are distinct from RyRs, and the high Ca2+ concentration
in the pipette solution and low ruthenium 360 concentrations
would be expected to inhibit the mRyR. While some mCa2 channel
properties seem to be reminiscent of the RAM, persistent high Ca2+
concentrations at the cytosolic site, i.e. in the pipette, would also
inactivate RAM. Conversely, no time-dependent change of ImCa2
was evident during continuous pulses in the present of 105 mM
Ca2+ in the pipette solution [15]. Therefore, mCa2 seems to repre-
sent a thus far unknown Ca2+ transport pathway.
3.5. Mitochondrial Na+/Ca2+-exchanger (mNCX)
The ﬁrst pathway for mitochondrial Ca2+ efﬂux was discovered
by Carafoli in 1974 as a Na+-dependent Ca2+ release mechanism in
isolated heart mitochondria [56]. In excitable tissue such as brain
and heart Ca2+ extrusion is mainly mediated by this Na+/Ca2+-ex-
changer (NCX). While the mNCX initially was believed to be elec-
troneutral, more recent evidence indicates that the transport
stoichiometry of this mechanism is 3Na+:Ca2+ as for the sarcolem-
mal NCX [57]. When present at the same side as Ca2+, potassium
may activate exchange rate. There are many inhibitors of the
Na+-dependent mitochondrial Ca2+ efﬂux including diltiazem, the
diltiazem-derivate CGP37157, verapamil, clonazepam and amilo-
ride [19]. Moreover, Sr2+ which may be transported slowly via this
pathway strongly inhibits Ca2+ transport rate over this mechanism.
Similar to the sarcolemmal NCX a reverse mode has been de-
scribed for the mNCX [58,59]. During metabolic inhibition an in-
crease of mitochondrial Ca2+ levels were observed despite a drop
of the mitochondrial membrane potential, which limited Ca2+ up-
take via the MCU or other electrogenic non-MCU Ca2+ uptake
routes. Moreover, this rise of mitochondria Ca2+ under metabolic
inhibition was suppressed in the absence of Na+ and in the pres-
ence of the NCX inhibitor CGP37157 [58]. This mode of action
may particularly be of functional importance in diseased states
with known alterations of cytosolic Na+ and Ca2+ levels such as
heart failure.
As for the other Ca2+ transporters there have been attempts to
purify the mNCX. So far three mammalian genes have been iso-
lated encoding for different sarcolemmal NCX isoforms, called
NCX1–3, sharing similar ionic afﬁnities and pharmacological char-
acteristics [60]. A protein from cardiac mitochondria was puriﬁed
which exhibited Na+/Ca2+ exchange properties when reconstituted
into lipid bilayers [61]. Antibodies raised against the putative
mNCX revealed a molecular weight of 110 kDa. However, the
molecular identity of this protein has not yet been identiﬁed. In
different regions of the brain all three NCX isoforms have been de-
tected using antibodies against the sarcolemmal NCX1–3 [62].
1980 U.C. Hoppe / FEBS Letters 584 (2010) 1975–1981However, currently it remains unknown how any of these sarco-
lemmal NCX subtypes might be target to mitochondria. Moreover,
in isolated mitochondria clonazepam may be used as effective
inhibitor of mNCX with an IC50 of 7 lM, while in intact cardiomyo-
cytes clonazepam had no obvious effect on contractility and Ca2+
transients at concentration up to 100 lM [63]. This difference in
drug sensitivity argues against the hypothesis that sarcolemmal
NCX isoforms also encode the mNCX.
3.6. Na+-independent Ca2+ efﬂux
Na+-independent Ca2+ efﬂux pathways are dominant in non-
excitable tissues such as liver and kidney, but may also be found
at low activity in heart mitochondria [64]. Ca2+ is transported
against the electrochemical gradient of the inner mitochondrial
membrane. Although this Ca2+ extrusion pathway was reported
to be electroneutral [65], thus far no anion nor any speciﬁc cation
which might be co-transported or exchanged with Ca2+, respec-
tively, have been identiﬁed. Therefore, this efﬂux route has been
suggested to exchange 2H+ for Ca2+, as H+ ﬂux is rather difﬁcult
to demonstrate. However, besides a simple passive exchange
mechanism additional energy dependency seems likely, as this
transport route may extrude Ca2+ against a gradient much greater
than twice the electrochemical proton gradient and may be
blocked by CN [10].
Thus, the importance of mitochondrial Ca2+ handling for various
cellular processes is increasingly being acknowledged, and mito-
chondrial Ca2+ routes may serve as potential therapeutic target in
the future. In recent years we gained more insight into different
Ca2+ transport mechanisms, although their precise physiological
role and interaction still has to be determined. Moreover, the
molecular structure and identity of all these mitochondrial Ca2+
transporters and channels currently remains elusive.4. Funding sources
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